Skip to main content
construction release_alert
The Scholars Team is working with OIT to resolve some issues with the Scholars search index
cancel

Dan German Blazer III

Professor of Surgery
Surgical Oncology
Box 3247 Med Ctr, Durham, NC 27710
485 Seeley G.Mudd Bldg., Searle Center, Durham, NC 27710

Current Appointments & Affiliations


Professor of Surgery · 2023 - Present Surgical Oncology, Surgery
Member of the Duke Cancer Institute · 2008 - Present Duke Cancer Institute, Institutes and Centers

In the News


Published May 17, 2016
Going to church could help you live longer, study says
Published June 17, 2013
Duke doctor duo share same name, ethics

View All News

Recent Publications


Survival Outcomes and Genetic Characteristics of Resected Pancreatic Acinar Cell Carcinoma.

Journal Article Annals of surgical oncology · March 2025 BackgroundPancreatic acinar cell carcinoma (pACC) is a rare neoplasm of the exocrine pancreas. There is a dearth of information about tumor characteristics and patient outcomes. This study describes the clinical characteristics, genetic alteration ... Full text Cite

Examining the Impact of Biopsy Technique on Clinical and Pathologic Outcomes in Dermatofibrosarcoma Protuberans: An International, Multi-Institutional Study.

Journal Article Ann Surg Oncol · February 27, 2025 BACKGROUND: The National Comprehensive Cancer Network (NCCN) guidelines recommend preoperative biopsy for diagnosing dermatofibrosarcoma protuberans (DFSP) but limited data support this approach. We characterized DFSP diagnostic practices and compared clin ... Full text Link to item Cite

Response to Central Boost Radiation Therapy in Unresectable Retroperitoneal Sarcoma: A Case Series.

Journal Article Adv Radiat Oncol · February 2025 PURPOSE: Optimal treatment of retroperitoneal sarcoma (RPS) remains undefined. Here, we report the feasibility of using high-dose boost radiation (3-4 Gy) to the central part of the tumor in patients with unresectable RPS. METHODS AND MATERIALS: Five patie ... Full text Link to item Cite
View All Publications

Recent Grants


Clinical Trials Umbrella - Scanned Beam

Clinical TrialPrincipal Investigator · Awarded by Massachusetts General Hospital · 2019 - 2025

A Phase I Trial of Talimogene Laherparepvec for the Treatment of Peritoneal Surface Malignancies (TEMPO)

Clinical TrialPrincipal Investigator · Awarded by Amgen, Inc. · 2019 - 2025

View All Grants

Education, Training & Certifications


Duke University · 1999 M.D.